EUR 115.88 For Business Accounts Only

Domainex Ltd - Company Review

Domainex Ltd - Company Review

Summary

Domainex Ltd (Domainex) is a biotechnology company that provides drug discovery technologies and services. The company offers drug discovery services in the areas of medicinal chemistry, computational chemistry, protein expression and purification, biochemical assay development, DMPK analysis, cell biology, combinatorial domain hunting, and hit identification using virtual or fragment-based approaches. It provides methyltransferases and solutions for the treatment of novel treatment for inflammatory diseases such as DMXD-011, a small-molecule orally-bio available inhibitor for rheumatoid arthritis and lupus. Domainex develops a range of drug target classes which include kinases, proteases, ion channels, proteins involved in epigenetics and protein-protein interactions. The company provides discovery technology platform such as combinatorial domain hunting and fragment-based screening. It develops therapies for oncology and autoimmune diseases. Domainex is headquartered in Saffron Walden, the UK.

This comprehensive company report of Domainex Ltd provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.